{"disease":{"id":"solid-tumors-and-hematologic-malignancy","name":"solid tumors and hematologic malignancy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02712905","title":"An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":116,"lead_sponsor_name":"Incyte Corporation","has_results":true},{"nct_id":"NCT02431260","title":"An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":69,"lead_sponsor_name":"Incyte Corporation","has_results":true},{"nct_id":"NCT02492789","title":"A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Atridia Pty Ltd.","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}